title: [Virological surveillance of pandemic (H1N1) 2009 virus and its genetic characteristics in Hunan Province, 2009-2011].
abstract: To understand and master the dynamic variation of the pandemic influenza A (H1N1) 2009 in Hunan province from 2009 to 2011, and to know the genetic characteristics and drug resistance of the pandemic (H1N1) 2009 viruses. Throat swab specimens of influenza-like illness patients were collected from sentinel hospitals and tested for influenza by fluorescent PCR or virus isolation methods. Partial isolates were selected for sequencing. The sequences were used for phylogenetic analysis by MEGA 5. 05 software. From the 20th week of 2009 to the 52nd week of 2011, 17 773 specimens were tested. 3 831 specimens were influenza-positive with a positive rate of 21. 6%, of which 1 794 were positive specimens of pandemic (H1N1) 2009, accounting for 46. 8%00 of the influenza-positives. There were 2 epidemic peaks of pandemic (H1N1) 2009, which were in the 41st-53rd week of 2009 and the 1st-12nd week of 2011, respectively. The HA genes of 23 strains that were selected for sequencing had close relationship; the distribution of strains in the phylogenetic tree was basically in chronological order. The complete genome sequence analysis showed that all of 8 gene segments of 7 strains were homologous to the vaccine strain, and there was no gene reassortment. The HA amino acid sites of the 23 strains were highly similar to the vaccine strain (98. 2% - 100. 0% in homology), but all 23 strains had P83S, S203T and 1321V mutations. The 222 site mutation that may lead to enhanced virulence was found in the A/Hunan/YQ30/2009 strain. The mutation was D222E. There was no oseltamivir resistance mutation found in all strains. The pandemic (H1N1) 2009 in Hunan province from 2009 to 2011 had a bimodal distribution. There was no large-scale variation of virus genes. The clinical use of oseltamivir was still effective. Key words: Pandemic (H1N1) 2009; Surveillance; Genetic characteristics
authors.affiliation: Hunan Provincial Center for Disease Control and Prevention, Changsha 410005, China. hnzhangh67@yahoo.com.cn
authors.forename: Hong
authors.initials: H
authors.lastname: Zhang
authors.forename: Yi-Wei
authors.initials: YW
authors.lastname: Huang
authors.forename: Yun-Zhi
authors.initials: YZ
authors.lastname: Liu
authors.forename: Fang-Cai
authors.initials: FC
authors.lastname: Li
authors.forename: Zhang
authors.initials: Z
authors.lastname: Chen
authors.forename: Wen-Chao
authors.initials: WC
authors.lastname: Li
authors.forename: Zhi-Hong
authors.initials: ZH
authors.lastname: Deng
authors.forename: Shi-Xiong
authors.initials: SX
authors.lastname: Hu
authors.forename: Li-Dong
authors.initials: LD
authors.lastname: Gao
mesh_terms: D000595:Amino Acid Sequence; D002681:China / Q000453:epidemiology; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000737:chemistry / Q000145:classification / Q000235:genetics* / Q000302:isolation & purification*; D007251:Influenza, Human / Q000453:epidemiology* / Q000821:virology*; D008969:Molecular Sequence Data; D058873:Pandemics; D010802:Phylogeny; D062486:Public Health Surveillance; D016415:Sequence Alignment; D014764:Viral Proteins / Q000737:chemistry / Q000235:genetics
chemical_list: D014764:Viral Proteins